There is substantial data demonstrating that polymorphisms in CCR5 are associated with variable susceptibility to HIV, AIDS progression rates, and CD4+ T cell count recovery during HAART [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [37], [38], [39], [40], [41]. This evidence concerns the gene CD4 and AIDS.